How has been the historical performance of Roselabs Finance?

Answer:The historical performance of Roselabs Finance shows a gradual increase in net sales, reaching 0.71 Cr in March 2025, up from 1.14 Cr in March 2024, and starting from zero in the previous years. The total operating income followed a similar trend, with a peak of 1.14 Cr in March 2024 and a slight decline in March 2025. The company has consistently reported no raw material costs or purchases of finished goods, indicating minimal operational activity. Employee costs have increased slightly from 0.05 Cr in March 2024 to 0.06 Cr in March 2025. Manufacturing expenses peaked at 1.13 Cr in March 2024 but decreased to 0.70 Cr in March 2025. Total expenditure, excluding depreciation, was 1.02 Cr in March 2025, down from 1.31 Cr in March 2024. Operating profit (PBDIT) showed a loss of -0.29 Cr in March 2025, worsening from -0.13 Cr in March 2024. Profit before tax also reflected losses, with -0.29 Cr in March 2025 compared to -0.13 Cr in March 2024. The profit after tax mirrored this trend, resulting in -0.29 Cr in March 2025. The company's reserves have been negative, standing at -14.73 Cr in March 2025, indicating ongoing financial challenges. The book value per share adjusted to -4.73 in March 2025, reflecting a decline from -4.44 in March 2024. Cash flow activities have remained stagnant, with no cash inflow or outflow reported across the years.

Breakdown:
Roselabs Finance's financial performance has shown a modest increase in net sales, reaching 0.71 Cr in March 2025, although it declined from the previous year's 1.14 Cr. The total operating income also decreased slightly to 0.71 Cr in March 2025. The company has maintained no raw material or finished goods purchases, with employee costs rising marginally to 0.06 Cr. Manufacturing expenses decreased significantly from 1.13 Cr in March 2024 to 0.70 Cr in March 2025, contributing to a total expenditure of 1.02 Cr in March 2025. Operating profit (PBDIT) reflected a loss of -0.29 Cr, worsening from -0.13 Cr in the prior year, while profit before tax and profit after tax both reported losses of -0.29 Cr. The company's reserves have remained negative, indicating financial strain, with a book value per share of -4.73 in March 2025. Overall, the cash flow situation has been stagnant, with no reported cash movements over the years.